Selected article for: "immune system and stem cell"
Author: Jayaramayya, Kaavya; Mahalaxmi, Iyer; Subramaniam, Mohana Devi; Raj, Neethu; Dayem, Ahmed Abdal; Lim, Kyung Min; Kim, Se Jong; An, Jong Yub; Lee, Yoonjoo; Choi, Yujin; Kirubhakaran, Arthi; Cho, Ssang-Goo; Vellingiri, Balachandar
Title: Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen
  • Cord-id: wcmmt5bl
  • Document date: 2020_8_31
    • ID: wcmmt5bl
    Snippet: The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse treatment options to effectively treat people worldwide. Since the immune system is at the hub of the infection, it is essential to regulate the dynamic balance in order to prevent the overexaggerated immune responses that subsequently result in multiorgan damage. The use of stem cells as treatment options has gained tremend
    Document: The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse treatment options to effectively treat people worldwide. Since the immune system is at the hub of the infection, it is essential to regulate the dynamic balance in order to prevent the overexaggerated immune responses that subsequently result in multiorgan damage. The use of stem cells as treatment options has gained tremend-ous momentum in the past decade. The revolutionary mea-sures in science have brought to the world mesenchymal stem cells (MSCs) and MSC-derived exosomes (MSC-Exo) as thera-peutic opportunities for various diseases. The MSCs and MSC-Exos have immunomodulatory functions; they can be used as therapy to strike a balance in the immune cells of patients with COVID-19. In this review, we discuss the basics of the cyto-kine storm in COVID-19, MSCs, and MSC-derived exosomes and the potential and stem-cell-based ongoing clinical trials for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • accurately guide and acute respiratory sars syndrome: 1
    • activate bind and acute respiratory: 1, 2, 3
    • activate bind and acute respiratory sars syndrome: 1, 2
    • activate bind and adaptive innate: 1
    • activate bind and adaptive innate immunity: 1
    • activate bind and adhesion molecule: 1
    • activate bind and lung dysfunction: 1
    • acute ards respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adaptive immune system innate: 1, 2, 3
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immunity: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute ards respiratory distress syndrome and administration route: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lncrna long noncoding rnas: 1
    • acute ards respiratory distress syndrome and long noncoding rnas: 1
    • acute ards respiratory distress syndrome and low immunogenicity: 1, 2, 3
    • acute ards respiratory distress syndrome and lung dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22